Röchling Medical

Plastic Manufacturing for Primary Packaging and Drug Delivery Systems

Neuhaus am Rennweg Waldweg 16, 98724 Neuhaus am Rennweg, Germany



Röchling Medical develops plastics processing and precision assembly solutions.

As a division of the Röchling Group, the company’s drug delivery, packaging, diagnostic disposables and surgical instruments provide a cost-effective and efficient solution for the pharmaceutical, diagnostics, and veterinary medicine industries.

Röchling Medical forms close partnerships with international universities and research organisations to ensure its high-quality research and development (R&D) services related to new materials and procedures meet the stringent needs of the medical industries.

Pharmaceutical product manufacturing services

Röchling Medical supports pharmaceutical, life science and medical device companies with product manufacturing services ranging from initial concept development to quality assurance, production and packaging.

The company has a comprehensive portfolio of manufacturing processes and techniques such as assembly, tooling, and various moulding types, including injection, extrusion, blow, multi-layer, stretch-blow and injection blow moulding.

Röchling Medical aims to increase return on investment (ROI) through options such as automated, semi-automated and manual cleanroom assembly and testing. Customers also benefit from the company’s sourcing capabilities and global infrastructure.

Dry powder and microsphere drug delivery solution

Röchling Medical’s advanced Sympfiny™ oral drug delivery system administers multi-particulate and dry powder pharmaceuticals using a syringe.

Using a technique that is often used for liquid drug delivery, the system has an integrated mechanism to ensure accurate and consistent dosing.

Tamper-evident closures

Röchling Medical’s ISO: 8317 certified R&D department used its expertise in closure manufacturing to design senior-friendly, tamper-evident and child-resistant closures (CRC).

The tamper-evident closures comprise liners, gaskets and desiccant chambers to meet client requirements.

Plastic primary packaging for healthcare products

Röchling Medical develops highly efficient plastic packaging for healthcare products, including items for the diagnostics and life science industries.

Cyclic olefin polymer (COP) is used as a glass substitute for medical vials, which are strong and lightweight, while also demonstrating high-transparency and barrier properties.

The COP vials are also suitable for parenteral formulations containing proteins and common sanitation processes.

Rapid prototyping and process development

Röchling Medical provides life science devices, rapid prototyping and process development services by collaborating with some of the largest original equipment manufacturers (OEM) in the industry.

The company also utilises this in-depth knowledge to offer validation services for medical device companies.

Surgical devices

Röchling Medical supplies surgical devices that are designed to be minimally invasive, including:

  • Cannulas and obturators
  • Trocar components
  • Vessel sealing devices
  • Laparoscopic jaws
  • Intravenous (IV) parts

Cleanroom-grade plastic production

Röchling Medical produces plastic packaging and medical supplies to meet the stringent regulatory requirements of the pharmaceutical, medical, diagnostics and veterinary sectors. The firm offers a wide range of sterilisation methods, including cleanroom-grade cleaning.

The company utilises its 8,000m2 cleanroom-grade facilities, which are subject to consistent monitoring and internal/external audits.  Employees are also regularly trained to ensure the latest regulatory requirements are implemented.

Dialysis

Röchling Medical develops and designs plastic components for the pharmaceutical, life science and medical technology sectors.

Vascular Surgery

Vascular surgery is a surgical sub-speciality where diseases of the vascular system are managed by medical therapy, minimally invasive catheter procedures and surgical reconstruction.

Röchling Growth in 2016-2017

Röchling continued its record of success in the 2016 financial year and Q1 2017, increasing its sales by 15.1% to €474.6 million in the first three months of 2017.

New Drug Delivery System Sympfiny®

It is often difficult to orally administer the correct amount of drugs accurately and safely to children due to their bitter taste.

Röchling Acquires FRANK plastic and Precision Medical Products

The Röchling Group has completed another step in its growth strategy. Subject to approval by the Cartel Office, the plastics specialist from Mannheim has acquired Baden-Württemberg-based medical and industrial technology provider FRANK plastic.

Röchling Medical Neuhaus GmbH & Co. KG